Literature DB >> 7396460

In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.

J Dzink, J G Bartlett.   

Abstract

In vitro susceptibility tests were performed on 84 strains of Clostridium difficile to 11 antimicrobial agents. All isolates were from the stools of patients with antibiotic-associated diarrhea or colitis in which there was a cytopathic toxin that was neutralized by Clostridium sordellii antitoxin. Over 95% of the strains were susceptible to vancomycin, penicillin G, ampicillin, and metronidazole at concentrations of 4 microgram/ml. Susceptibility to clindamycin was variable; 60% of the strains were susceptible at 1 microgram/ml, and 9% were resistant at 128 microgram/ml. Studies of individual isolates showed that a major portion of the strains were relatively susceptible to the antimicrobial agent implicated in causing the disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7396460      PMCID: PMC283855          DOI: 10.1128/AAC.17.4.695

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Antimicrobial agent-induced diarrhea--a bacterial disease.

Authors:  W L George; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

2.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

3.  Oral vancomycin for antibiotic-associated pseudomembranous colitis.

Authors:  F Tedesco; R Markham; M Gurwith; D Christie; J G Bartlett
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

4.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

5.  Clindamycin-associated colitis. Review of the clinical spectrum of 47 cases.

Authors:  F J Tedesco
Journal:  Am J Dig Dis       Date:  1976-01

6.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

7.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

8.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

9.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

10.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

View more
  24 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Homology of a transferable tetracycline resistance determinant of Clostridium difficile with Streptococcus (Enterococcus) faecalis transposon Tn916.

Authors:  H Hächler; F H Kayser; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

3.  Genetic characterization of a Clostridium difficile erythromycin-clindamycin resistance determinant that is transferable to Staphylococcus aureus.

Authors:  H Hächler; B Berger-Bächi; F H Kayser
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Application of chromosomal restriction endonuclease digest analysis for use as typing method for Clostridium difficile.

Authors:  P G Peerbooms; P Kuijt; D M Maclaren
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

5.  Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.

Authors:  F Barbut; D Decré; B Burghoffer; D Lesage; F Delisle; V Lalande; M Delmée; V Avesani; N Sano; C Coudert; J C Petit
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

Review 6.  Update on pseudomembranous colitis.

Authors:  J Silva
Journal:  West J Med       Date:  1989-12

7.  Susceptibility of Clostridium difficile to metronidazole, its bioactive metabolites and tinidazole.

Authors:  R Bannatyne; J Jackowski
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 8.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

9.  Investigation of an outbreak of antibiotic-associated colitis by various typing methods.

Authors:  J Wüst; N M Sullivan; U Hardegger; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

10.  In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics.

Authors:  A W Chow; N Cheng; K H Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.